Target Name: ZNF682
NCBI ID: G91120
Review Report on ZNF682 Target / Biomarker Content of Review Report on ZNF682 Target / Biomarker
ZNF682
Other Name(s): Zinc finger protein 682, transcript variant 1 | ZN682_HUMAN | ZNF682 variant 2 | Zinc finger protein 682 (isoform 1) | ZNF682 variant 1 | BC39498_3 | Zinc finger protein 682 | zinc finger protein 682 | Zinc finger protein 682, transcript variant 2 | Zinc finger protein 682 (isoform 2)

ZNF682: A Potential Drug Target and Biomarker for Neurodegenerative Disorders

Neurodegenerative disorders are a group of progressive diseases that affect the nervous system and can include a wide range of conditions, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. These conditions are characterized by the progressive loss of nerve cells and the damage to the nervous system, leading to a range of symptoms and impairments.

One of the most promising avenues for the development of new treatments for neurodegenerative disorders is the targeting of protein misfolding, which is a process that occurs when proteins become misfolded and cannot function properly. ZNF682, a zinc finger protein 682, has been identified as a potential drug target and biomarker for neurodegenerative disorders.

ZNF682: Structure and Function

ZNF682 is a member of the ZNF family of proteins, which are known for their role in regulating gene expression and are implicated in a wide range of cellular processes, including cell growth, differentiation, and stress response. ZNF682 is composed of 191 amino acid residues and has a calculated molecular weight of 21 kDa.

The ZNF682 protein is characterized by a zinc finger motif, which is a common structural feature that consists of a central zinc atom that is surrounded by four amino acids. This motif is present in multiple ZNF proteins and is thought to play a role in the regulation of gene expression and protein stability.

Functional studies have shown that ZNF682 is involved in a wide range of cellular processes, including cell growth, differentiation, and stress response. For example, ZNF682 has been shown to be involved in the regulation of cell cycle progression, cell survival, and the response to stress.

In addition to its role in cellular processes, ZNF682 is also a potential drug target. The misfolding of proteins is a common problem that can contribute to the development of a wide range of diseases, including neurodegenerative disorders. By targeting ZNF682, researchers may be able to develop new treatments for neurodegenerative disorders.

The Potential for Therapeutic Applications

The misfolding of proteins is a common problem that can contribute to the development of a wide range of diseases, including neurodegenerative disorders. ZNF682 has been shown to be involved in the regulation of protein misfolding, which suggests that it may be a useful target for the development of new treatments for neurodegenerative disorders.

One potential approach to targeting ZNF682 is the use of small molecules that can modulate the activity of the protein. For example, researchers have shown that the zinc ion can interact with the protein and alter its activity. Therefore, researchers may be able to develop small molecules that interact with ZNF682 and modulate its activity.

Another potential approach to targeting ZNF682 is the use of antibodies that recognize the protein. Researchers have shown that antibodies can be used to detect and label specific proteins in cells, which could be useful for the development of diagnostic tests for neurodegenerative disorders.

Conclusion

ZNF682 is a zinc finger protein 682 that has been identified as a potential drug target and biomarker for neurodegenerative disorders. Its role in the regulation of protein misfolding and its potential therapeutic applications make it an attractive target for researchers to explore. Further studies are needed to determine the full potential of ZNF682 as a drug target and biomarker for neurodegenerative disorders.

Protein Name: Zinc Finger Protein 682

Functions: May be involved in transcriptional regulation

The "ZNF682 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF682 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A